Company / Operating Margin
ENDONOVO THERAPEUTICS, INC. Operating Margin History
FY2011-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-2411.7%
FY2022
5-year range
-4995.3% / -1228.1%
FY2018-FY2022
Trend
+20.8%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin returned to growth in FY2022 after 2 years of decline, reaching -2411.7%.
Based on SEC 10-K filings.
-2411.7% in FY2022 with a 3-year CAGR of -1183.6%.
Declined from -1756.5% to -2411.7% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -1183.6pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2022, operating margin increased 20.8% year-over-year.
- Peak operating margin was recorded in FY2011.
- Lowest operating margin in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -76.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -2411.7% | +20.8% |
| FY2021 | -3045.7% | -73.4% |
| FY2020 | -1756.5% | -43.0% |
| FY2019 | -1228.1% | +75.4% |
| FY2018 | -4995.3% | - |
| FY2016 | - | - |
| FY2015 | -60132.7% | -563.9% |
| FY2014 | -9057.6% | -4218.5% |
| FY2011 | -209.7% | - |
As of FY2022 · SEC 10-K · Updated Jun 29, 2026